Article
The novel BLM3 gene encodes a protein that protects against lethal effects of oxidative damage.
Cellular and molecular biology (Noisy-le-Grand, France) - 1 Nov 2001
Febres D E, Pramanik A, Caton M, Doherty K, McKoy J, Garcia E, Alejo W, Moore C W
Abstract excerpt
Mutational alteration of the BLM3 gene in Saccharomyces cerevisiae confers hypersensitivities to lethal effects of ionizing radiation, anticancer bleomycins and structurally-related phleomycins. Bleomycin is used clinically in the treatment of many types of cancers, including Kaposi's sarcoma. The BLM3 gene was cloned from a genomic library by complementing the drug hypersensitivities conferred by the codominant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
